Literature DB >> 24916125

Next generation drying technologies for pharmaceutical applications.

Robert H Walters1, Bakul Bhatnagar1, Serguei Tchessalov1, Ken-Ichi Izutsu2, Kouhei Tsumoto3, Satoshi Ohtake4.   

Abstract

Drying is a commonly used technique for improving the product stability of biotherapeutics. Typically, drying is accomplished through freeze-drying, as evidenced by the availability of several lyophilized products on the market. There are, however, a number of drawbacks to lyophilization, including the lengthy process time required for drying, low energy efficiency, high cost of purchasing and maintaining the equipment, and sensitivity of the product to freezing and various other processing-related stresses. These limitations have led to the search for next-generation drying methods that can be applied to biotherapeutics. Several alternative drying methods are reviewed herein, with particular emphasis on methods that are commonly employed outside of the biopharmaceutical industry including spray drying, convective drying, vacuum drying, microwave drying, and combinations thereof. Although some of the technologies have already been implemented for processing biotherapeutics, others are still at an early stage of feasibility assessment. An overview of each method is presented, detailing the comparison to lyophilization, examining the advantages and disadvantages of each technology, and evaluating the potential of each to be utilized for drying biotherapeutic products.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Keywords:  dehydration; drying; foam drying; freeze-drying; hybrid drying; microwave; processing; proteins; spray drying; supercritical fluids

Mesh:

Substances:

Year:  2014        PMID: 24916125     DOI: 10.1002/jps.23998

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

Review 1.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

2.  Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.

Authors:  Giovanna Rassu; Elena Soddu; Massimo Cossu; Antonio Brundu; Guido Cerri; Nicola Marchetti; Luca Ferraro; Raymond F Regan; Paolo Giunchedi; Elisabetta Gavini; Alessandro Dalpiaz
Journal:  J Control Release       Date:  2015-01-22       Impact factor: 9.776

3.  Effects of Drying Process on an IgG1 Monoclonal Antibody Using Solid-State Hydrogen Deuterium Exchange with Mass Spectrometric Analysis (ssHDX-MS).

Authors:  Ehab M Moussa; Nathan E Wilson; Qi Tony Zhou; Satish K Singh; Sandeep Nema; Elizabeth M Topp
Journal:  Pharm Res       Date:  2018-01-03       Impact factor: 4.200

Review 4.  Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.

Authors:  Anagha Bhakay; Mahbubur Rahman; Rajesh N Dave; Ecevit Bilgili
Journal:  Pharmaceutics       Date:  2018-07-08       Impact factor: 6.321

Review 5.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

6.  Protection by desiccation-tolerance proteins probed at the residue level.

Authors:  Candice J Crilly; Julia A Brom; Owen Warmuth; Harrison J Esterly; Gary J Pielak
Journal:  Protein Sci       Date:  2021-11-24       Impact factor: 6.725

Review 7.  Freeze-drying for the preservation of immunoengineering products.

Authors:  Nagavendra Kommineni; Arun Butreddy; Vaskuri G S Sainaga Jyothi; Pavimol Angsantikul
Journal:  iScience       Date:  2022-09-13

Review 8.  Pharmaceutical protein solids: Drying technology, solid-state characterization and stability.

Authors:  Yuan Chen; Tarun Tejasvi Mutukuri; Nathan E Wilson; Qi Tony Zhou
Journal:  Adv Drug Deliv Rev       Date:  2021-03-08       Impact factor: 15.470

9.  Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study.

Authors:  Suzan M Mansour; Rehab N Shamma; Kawkab A Ahmed; Nirmeen A Sabry; Gamal Esmat; Azza A Mahmoud; Amr Maged
Journal:  Int Immunopharmacol       Date:  2021-07-23       Impact factor: 4.932

Review 10.  Development of thermostable vaccine adjuvants.

Authors:  Yizhi Qi; Christopher B Fox
Journal:  Expert Rev Vaccines       Date:  2021-06-26       Impact factor: 5.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.